Specificity of cognitive deficits in bipolar disorder versus schizophrenia. A systematic review. 2006

Claire Daban, and Anabel Martinez-Aran, and Carla Torrent, and Rafael Tabarés-Seisdedos, and Vicent Balanzá-Martínez, and Jose Salazar-Fraile, and Gabriel Selva-Vera, and Eduard Vieta
Bipolar Disorders Program, Hospital Clinic, University of Barcelona, IDIBAPS, Barcelona, Spain.

BACKGROUND More and more epidemiological, genetic and neuroimaging studies show similarities between bipolar disorder (BD) and schizophrenia (SZ). Cognitive functions are known to be highly impaired in SZ and are increasingly studied in BD. When both populations are compared, the conclusions appear to be contradictory. The purpose of this review is to help define the profile of cognitive deficits in BD and in SZ. METHODS A systematic review of the literature of neuropsychological studies comparing BD and SZ was made, beginning in January 1990 and ending in January 2005. Thirty-eight studies met the required quality criteria and were included in this review. RESULTS Bipolar patients exhibit extensive cognitive abnormalities with a pattern of deficits that is not unique to this disease. However, when compared to schizophrenic patients, bipolar patients demonstrate a lesser degree of deficits, particularly concerning premorbid and current intelligence quotient and perhaps attention, verbal memory and executive functions. When looking into effect sizes, there seem to be different profiles even in studies finding no significant differences. CONCLUSIONS The neuropsychological differences reported between both groups could be due to the presence of psychotic features, to environmental factors (stressful events, duration of the disease and number of hospitalisations) and could also be related to differences during the neurodevelopmental phase. Further studies should confirm whether these results are truly related to different neurobiological backgrounds.

UI MeSH Term Description Entries
D009483 Neuropsychological Tests Tests designed to assess neurological function associated with certain behaviors. They are used in diagnosing brain dysfunction or damage and central nervous system disorders or injury. Aphasia Tests,Cognitive Test,Cognitive Testing,Cognitive Tests,Memory for Designs Test,Neuropsychological Testing,AX-CPT,Behavioral Assessment of Dysexecutive Syndrome,CANTAB,Cambridge Neuropsychological Test Automated Battery,Clock Test,Cognitive Function Scanner,Continuous Performance Task,Controlled Oral Word Association Test,Delis-Kaplan Executive Function System,Developmental Neuropsychological Assessment,Hooper Visual Organization Test,NEPSY,Neuropsychologic Tests,Neuropsychological Test,Paced Auditory Serial Addition Test,Repeatable Battery for the Assessment of Neuropsychological Status,Rey-Osterrieth Complex Figure,Symbol Digit Modalities Test,Test of Everyday Attention,Test, Neuropsychological,Tests, Neuropsychological,Tower of London Test,Neuropsychologic Test,Test, Cognitive,Testing, Cognitive,Testing, Neuropsychological,Tests, Cognitive
D003072 Cognition Disorders Disorders characterized by disturbances in mental processes related to learning, thinking, reasoning, and judgment. Overinclusion,Disorder, Cognition,Disorders, Cognition
D006304 Health Status The level of health of the individual, group, or population as subjectively assessed by the individual or by more objective measures. General Health,General Health Level,General Health Status,Level of Health,Overall Health,Overall Health Status,General Health Levels,Health Level,Health Level, General,Health Levels,Health Status, General,Health Status, Overall,Health, General,Health, Overall,Level, General Health,Levels, General Health,Status, General Health,Status, Health,Status, Overall Health
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001714 Bipolar Disorder A major affective disorder marked by severe mood swings (manic or major depressive episodes) and a tendency to remission and recurrence. Affective Psychosis, Bipolar,Bipolar Disorder Type 1,Bipolar Disorder Type 2,Bipolar Mood Disorder,Depression, Bipolar,Manic Depression,Manic Disorder,Manic-Depressive Psychosis,Psychosis, Manic-Depressive,Type 1 Bipolar Disorder,Type 2 Bipolar Disorder,Psychoses, Manic-Depressive,Bipolar Affective Psychosis,Bipolar Depression,Bipolar Disorders,Bipolar Mood Disorders,Depression, Manic,Depressions, Manic,Disorder, Bipolar,Disorder, Bipolar Mood,Disorder, Manic,Manic Depressive Psychosis,Manic Disorders,Mood Disorder, Bipolar,Psychoses, Bipolar Affective,Psychoses, Manic Depressive,Psychosis, Bipolar Affective,Psychosis, Manic Depressive
D012559 Schizophrenia A severe emotional disorder of psychotic depth characteristically marked by a retreat from reality with delusion formation, HALLUCINATIONS, emotional disharmony, and regressive behavior. Dementia Praecox,Schizophrenic Disorders,Disorder, Schizophrenic,Disorders, Schizophrenic,Schizophrenias,Schizophrenic Disorder
D012680 Sensitivity and Specificity Binary classification measures to assess test results. Sensitivity or recall rate is the proportion of true positives. Specificity is the probability of correctly determining the absence of a condition. (From Last, Dictionary of Epidemiology, 2d ed) Specificity,Sensitivity,Specificity and Sensitivity
D012720 Severity of Illness Index Levels within a diagnostic group which are established by various measurement criteria applied to the seriousness of a patient's disorder. Illness Index Severities,Illness Index Severity
D014150 Antipsychotic Agents Agents that control agitated psychotic behavior, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect. They are used in SCHIZOPHRENIA; senile dementia; transient psychosis following surgery; or MYOCARDIAL INFARCTION; etc. These drugs are often referred to as neuroleptics alluding to the tendency to produce neurological side effects, but not all antipsychotics are likely to produce such effects. Many of these drugs may also be effective against nausea, emesis, and pruritus. Antipsychotic,Antipsychotic Agent,Antipsychotic Drug,Antipsychotic Medication,Major Tranquilizer,Neuroleptic,Neuroleptic Agent,Neuroleptic Drug,Neuroleptics,Tranquilizing Agents, Major,Antipsychotic Drugs,Antipsychotic Effect,Antipsychotic Effects,Antipsychotics,Major Tranquilizers,Neuroleptic Agents,Neuroleptic Drugs,Tranquillizing Agents, Major,Agent, Antipsychotic,Agent, Neuroleptic,Drug, Antipsychotic,Drug, Neuroleptic,Effect, Antipsychotic,Major Tranquilizing Agents,Major Tranquillizing Agents,Medication, Antipsychotic,Tranquilizer, Major

Related Publications

Claire Daban, and Anabel Martinez-Aran, and Carla Torrent, and Rafael Tabarés-Seisdedos, and Vicent Balanzá-Martínez, and Jose Salazar-Fraile, and Gabriel Selva-Vera, and Eduard Vieta
May 2018, Pharmacopsychiatry,
Claire Daban, and Anabel Martinez-Aran, and Carla Torrent, and Rafael Tabarés-Seisdedos, and Vicent Balanzá-Martínez, and Jose Salazar-Fraile, and Gabriel Selva-Vera, and Eduard Vieta
January 2016, NPJ schizophrenia,
Claire Daban, and Anabel Martinez-Aran, and Carla Torrent, and Rafael Tabarés-Seisdedos, and Vicent Balanzá-Martínez, and Jose Salazar-Fraile, and Gabriel Selva-Vera, and Eduard Vieta
January 2013, Frontiers in psychiatry,
Claire Daban, and Anabel Martinez-Aran, and Carla Torrent, and Rafael Tabarés-Seisdedos, and Vicent Balanzá-Martínez, and Jose Salazar-Fraile, and Gabriel Selva-Vera, and Eduard Vieta
January 2015, Neuropsychiatric disease and treatment,
Claire Daban, and Anabel Martinez-Aran, and Carla Torrent, and Rafael Tabarés-Seisdedos, and Vicent Balanzá-Martínez, and Jose Salazar-Fraile, and Gabriel Selva-Vera, and Eduard Vieta
January 2007, Neuropsychiatrie : Klinik, Diagnostik, Therapie und Rehabilitation : Organ der Gesellschaft Osterreichischer Nervenarzte und Psychiater,
Claire Daban, and Anabel Martinez-Aran, and Carla Torrent, and Rafael Tabarés-Seisdedos, and Vicent Balanzá-Martínez, and Jose Salazar-Fraile, and Gabriel Selva-Vera, and Eduard Vieta
June 2024, IBRO neuroscience reports,
Claire Daban, and Anabel Martinez-Aran, and Carla Torrent, and Rafael Tabarés-Seisdedos, and Vicent Balanzá-Martínez, and Jose Salazar-Fraile, and Gabriel Selva-Vera, and Eduard Vieta
May 2021, International journal of bipolar disorders,
Claire Daban, and Anabel Martinez-Aran, and Carla Torrent, and Rafael Tabarés-Seisdedos, and Vicent Balanzá-Martínez, and Jose Salazar-Fraile, and Gabriel Selva-Vera, and Eduard Vieta
June 2019, Schizophrenia research. Cognition,
Claire Daban, and Anabel Martinez-Aran, and Carla Torrent, and Rafael Tabarés-Seisdedos, and Vicent Balanzá-Martínez, and Jose Salazar-Fraile, and Gabriel Selva-Vera, and Eduard Vieta
January 2015, Trends in psychiatry and psychotherapy,
Claire Daban, and Anabel Martinez-Aran, and Carla Torrent, and Rafael Tabarés-Seisdedos, and Vicent Balanzá-Martínez, and Jose Salazar-Fraile, and Gabriel Selva-Vera, and Eduard Vieta
January 2001, Psychiatria polska,
Copied contents to your clipboard!